@dansfera: In the evolving landscape of clinical research, the battle for patient access is heating up as Contract Research Organizations (CROs) strategically acquire sites. This shift is redefining the competitive advantage in the industry, where control over sites can make or break a winning proposal. Did you know that having the right partnerships could mean the difference between landing a major study for a big player like Pfizer and losing it to a rival? Discover how CROs and site networks are leveling the playing field, and why the right connections are now more crucial than ever. This insightful discussion sheds light on the strategic moves reshaping the future of clinical trials. Dive into the dynamics of competition that could change the game! #ClinicalResearch #CROs #SiteNetworks #PatientAccess #ClinicalTrials #Pharma #DrugDevelopment #HealthcareInnovation #ResearchStrategies #BiddingWar
